Le Lézard
Classified in: Health
Subject: SVY

PharmaFocus: Visual Analysis of Immuno-Oncology Development and Opportunities



NEW YORK, Oct. 6, 2017 /PRNewswire/ -- PharmaFocus: Visual Analysis of Immuno-Oncology Development and Opportunities

Summary

Read the full report: https://www.reportlinker.com/p05134501


Immuno-Oncology (IO) is uniquely positioned to become the fifth pillar of cancer treatment alongside surgery, radiotherapy, chemotherapy, and other targeted treatments. In order to assist our clients with navigating the burgeoning amount information arising as a result of the rapidly growing field of IO clinical research, GlobalData is offering a comprehensive analysis of both pipeline and marketed active immunity IO therapies.

Scope
Key Topics Covered -
- Immune Checkpoint Modulators - Trends in Clinical Trial Development
- Competitive Assessment of Marketed PD-(L)1 Checkpoint Modulators
- Emergence of New Immune Checkpoint Targets
- Clinical and Commercial Opportunities for Highly Anticipated CAR Cell Therapies
- Cell Vaccines: Steady Development Stimulated by Prior IO Success
- Promising IO-IO Combinations Utilizing Oncolytic Viruses

Reasons to buy
- The PharmaFocus consists of a highly-visual slide deck that is intended to facilitate the dissemination of aggregated data and insights from analyses of over 800 IO products that are either marketed or in Phase I-III of clinical development.
- Types of graphical analyses include - Cumulative Plots, Aggregated Bubble Plots, Pie Charts, Matrix Analyses
- Unique, actionable insights applicable to IO drugs in five major categories: Immune Checkpoint Modulators, Cellular Immunotherapies, Oncolytic Viruses, Peptide Vaccines, and Bispecific T-Cell Engagers are provided in this report.
- Analysis of over 4000 clinical trials enrolling patients with 18 solid tumors and eight hematological cancers are included.

Read the full report: https://www.reportlinker.com/p05134501

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

https://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 19:01
Philanthropists nationwide answered the call to accelerate the pace of Alzheimer's research by giving an unprecedented $109 million to the Alzheimer's Association for research, it was announced today at the Alzheimer's Association International...

at 17:47
Original Notice Why you should take note? The Public Health Agency of Canada is collaborating with provincial public health partners, the Canadian Food Inspection Agency and Health Canada to investigate outbreaks of Salmonella...

at 13:26
Integrated speech reporting and diagnostic decision support workflow to be demonstrated at AHRA 2018 Elsevier, the global information analytics business specializing in science and health, and part of RELX Group, announced today that it has entered...

at 09:00
NORWALK, Conn., July 21, 2018 /PRNewswire-PRWeb/ -- As Nigel Lythgoe's, National Dance Day approaches, July 28, 2018, we are taking it global to help fund Wigs & Wishes in the provision of wigs for Warriors battling cancer and granting the last...

20 jui 2018
TRT Holdings, Inc., the majority shareholder of Gold's Gym since 2004, says it will put the iconic fitness brand up for sale to focus more on its core business. It has retained Piper Jaffray & Co. to conduct a sales process. "Over the years we have...

20 jui 2018
Mondel?z Canada is recalling Christie brand Ritz Bits Sandwiches (cheese and pizza flavours) from the marketplace due to possible Salmonella contamination. Consumers should not consume the recalled products described below. The following products...




News published on 6 october 2017 at 11:12 and distributed by: